Is CRXTQ or O a better dividend investment in 2026?

CRXTQ currently yields 142857.14% with a 5% 5-year dividend growth rate. O yields 5.28% with 3.2% growth. The better choice depends on your goal: CRXTQ offers higher current income.

What is the dividend yield difference between CRXTQ and O?

CRXTQ has a forward dividend yield of 142857.14% ($2.00/share annually). O yields 5.28% ($3.23/share annually). The yield gap is 142851.86 percentage points.

Home › Compare › CRXTQ vs O

CRXTQ vs O: Dividend Comparison 2026

CRXTQ yields 142857.14% · O yields 5.28%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CRXTQ wins by $1.703105290929614e+28M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CRXTQ

● Live price

142857.14%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.703105290929614e+28M

Annual income

$17,007,633,297,048,937,000,000,000,000,000,000.00

Full CRXTQ calculator →

Realty Income Corporation

● Live price

5.28%

Share price

$61.18

Annual div

$3.23

5Y div CAGR

15.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34.2K

Annual income

$5,098.20

Full O calculator →

Portfolio growth — CRXTQ vs O

📍 CRXTQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CRXTQ	O
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CRXTQ + O cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CRXTQ pays

O pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRXTQ

Annual income on $10K today (after 15% tax)

$12,142,857.14/yr

After 10yr DRIP, annual income (after tax)

$14,456,488,302,491,595,000,000,000,000,000,000.00/yr

Annual income on $10K today (after 15% tax)

$448.90/yr

After 10yr DRIP, annual income (after tax)

$4,333.47/yr

At 15% tax rate, CRXTQ beats the other by $14,456,488,302,491,595,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRXTQ + O for your $10,000?

CRXTQ: 50%O: 50%

100% O50/50100% CRXTQ

Portfolio after 10yr

$8.51552645464807e+27M

Annual income

$8,503,816,648,524,468,000,000,000,000,000,000.00/yr

Blended yield

99.86%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

CRXTQ

Analyst Ratings

Buy

Hold

Consensus: Hold

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$64.00

+4.6% upside vs current

Range: $60.00 — $69.00

Altman Z

1.0

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRXTQ buys

O buys

No recent congressional trades found for CRXTQ or O in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCRXTQO

Forward yield	142857.14% ✓	5.28%
Annual dividend / share	$2.00	$3.23 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.1% ✓
Portfolio after 10y	$1.703105290929614e+28M	$34.2K ✓
Annual income after 10y	$17,007,633,297,048,937,000,000,000,000,000,000.00 ✓	$5,098.20
Total dividends collected	$1.70295189426983e+28M	$20.7K ✓
Payment frequency	quarterly	monthly
Sector	Stock	REIT
Analyst consensus	Hold	Hold

Year-by-year: CRXTQ vs O ($10,000, DRIP)

Year	CRXTQ Portfolio	CRXTQ Income/yr	O Portfolio	O Income/yr	Gap
1← crossover	$14,296,414	$14,285,714.29	$10,818	$607.86	+$14.29M → CRXTQ
2	$19,102,632,658	$19,087,335,494.95	$11,786	$741.30	+$19102.62M → CRXTQ
3	$23,856,124,353,624	$23,835,684,536,679.88	$12,944	$910.50	+$23856124.34M → CRXTQ
4	$27,845,102,711,212,050	$27,819,576,658,153,670.00	$14,343	$1,127.28	+$27845102711.20M → CRXTQ
5	$30,376,787,884,694,190,000	$30,346,993,624,793,194,000.00	$16,053	$1,408.17	+$30376787884694.17M → CRXTQ
6	$30,972,831,647,170,750,000,000	$30,940,328,484,134,132,000,000.00	$18,167	$1,776.65	+$30972831647170752.00M → CRXTQ
7	$29,516,720,240,819,920,000,000,000	$29,483,579,310,957,454,000,000,000.00	$20,815	$2,266.60	+$29516720240819920896.00M → CRXTQ
8	$26,290,911,335,300,946,000,000,000,000	$26,259,328,444,643,270,000,000,000,000.00	$24,179	$2,927.66	+$2.6290911335300947e+22M → CRXTQ
9	$21,887,488,081,496,375,000,000,000,000,000	$21,859,356,806,367,600,000,000,000,000,000.00	$28,521	$3,833.95	+$2.1887488081496375e+25M → CRXTQ
10	$17,031,052,909,296,140,000,000,000,000,000,000	$17,007,633,297,048,937,000,000,000,000,000,000.00	$34,218	$5,098.20	+$1.703105290929614e+28M → CRXTQ

CRXTQ vs O: Complete Analysis 2026

CRXTQ — Stock

Clarus Therapeutics Holdings, Inc., a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen therapies for inflammatory breast disease and certain forms of breast cancer; and license agreement with The Royal Institution for the Advancement of Learning/McGill University to develop and commercialize McGill's proprietary technology designed to treat conditions associated with CoQ10 deficiencies in humans. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois. On September 5, 2022, Clarus Therapeutics Holdings, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full CRXTQ Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →

📬

Get this CRXTQ vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRXTQ vs SCHD CRXTQ vs JEPI CRXTQ vs KO CRXTQ vs MAIN CRXTQ vs STAG CRXTQ vs ADC CRXTQ vs NNN CRXTQ vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.